Dumadag, Baby Girl .
HRN: 24-14-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/24/2023
12/01/2023
IVT
33mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes